Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can music and an AI app shield new mothers from postnatal depression?

NCT ID NCT07773259

Prevention Sponsor: KK Women's and Children's Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 19, 2026 · Last updated Aug 20, 2026 · Updated 1 time

Summary

This trial tests whether a collaborative psychological model—combining daily music listening, a smartphone app with AI chatbot support and mindfulness exercises, telephone check-ins, and wearable monitoring—can reduce the risk of postnatal depression and persistent pain after childbirth. Around 2,000 women giving birth at a single hospital will be randomly assigned to receive this program or standard care, with partners also invited to participate. The study measures depression scores and pain at 8 weeks postpartum to see if the digital toolkit makes a meaningful difference.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A collaborative psychological model combining daily music listening, a mobile app with AI chatbot and mindfulness guidance, telephone support, and wearable monitoring
What this could lead to
If effective, this approach could offer a practical, scalable way to prevent and manage postnatal depression and persistent pain, improving outcomes for mothers and families.
What could go wrong
The trial is large but the intervention is complex and relies on adherence; results may vary, and the digital tools may not suit everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 3,470 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Oct 2026

An estimate. Start dates often move.

Expected to finish

Dec 2031

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

21 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria (Mothers): * Healthy (American Society of Anesthesiologists (ASA) physical status II); * Parturient women at term (36 weeks' gestation or more, nulliparous and multiparous); * With a singleton fetus; * Planning to have childbirth and delivery at study site; * Patients with prior mental health history, and current active psychiatric care will also be recruited. Inclusion Criteria (Fathers): * Identified partner (e.g., husband or significant other) of the enrolled pregnant patient; * Aged 21 years and above; * Able to understand the study procedures and willing to participate in the 8 weeks postpartum assessment. Exclusion Criteria (Mothers): * History of intravenous drug or opioid abuse; * Previous history of chronic pain syndrome. Exclusion Criteria (Fathers): * Unable to provide informed consent (e.g., cognitive impairment, language barriers without available translation support); * Any condition that, in the opinion of the investigators, would make participation inappropriate (e.g., severe psychiatric or medical condition).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Depression are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Depression depressive disorder mental disorder Pain postpartum depression psychiatric disorder Psychological Well-Being puerperal disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Depression Mental health Pain Postpartum

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.